news & events contact search about axogen our products for patients healthcare professionals investors We use cookies to personalise content, to provide social media features and to analyse our traffic and improve our site. We also share information about your use of our site with our social media, advertising and analytics partners for these purposes. You consent to our cookies if you continue to use our website. To find out more, please see our Privacy Statement. accept Management Team Karen Zaderej Chairman, Chief Executive Officer, and President learn more Brad Ottinger General Counsel and Chief Compliance Officer learn more Peter J. Mariani Executive Vice President and Chief Financial Officer learn more Eric A. Sandberg Chief Commercial Officer learn more Maria Martinez Chief Human Resources Officer learn more Isabelle Billet Chief Strategy and Business Development Officer learn more Erick DeVinney Vice President of Peripheral Nerve Science and Clinical Innovation learn more Mike Donovan Vice President, Operations learn more Ivica Ducic, M.D. Medical Director learn more Mark Friedman, Ph.D. Vice President of Regulatory Affairs and Policy learn more Angelo G. Scopelianos, Ph.D. Vice President, Research and Development learn more 13631 Progress Blvd, Suite 400 Alachua, FL 32615 contact © 2021 Axogen Corporation The stylized "a" logo and Avance Nerve Graft are registered trademarks of Axogen Corporation. top A letter from our CEO on covid-19 | read more

about axogen investors news contact .axogen-svg_st0 { display: none; fill-rule: evenodd; clip-rule: evenodd; fill: #056dea; } .axogen-svg_st1 { fill: #056cea; } healthcare professionals patients covid-19 statement a letter from our ceo overview news / events financial info stock data sec filings governance additional info investor tools Press Releases year All Years category All Releases Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum Nov 10, 2021 Axogen, Inc. to Participate at Jefferies London Healthcare Conference Nov 4, 2021 Axogen, Inc. Reports 2021 Third Quarter Financial Results Nov 3, 2021 Axogen, Inc. to Report Third Quarter Financial Results and Host Conference Call on November 3, 2021 Oct 13, 2021 Axogen to Participate in the 76th Annual Meeting of the American Society for Surgery of the Hand Sep 22, 2021 Axogen RECON(SM) Clinical Study Completes Subject Follow-up Sep 1, 2021 Axogen, Inc. Reports 2021 Second Quarter Financial Results Aug 4, 2021 Axogen, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference Jul 22, 2021 Axogen, Inc. Appoints John H. Johnson to Board of Directors Jul 19, 2021 Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021 Jul 14, 2021 1 2 3 4 5 6 7 8 9 10 ...26 Next 13631 Progress Blvd, Suite 400 Alachua, FL 32615 contact careers privacy policy terms of use legal notices © 2021 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.